Hospitals nationwide will begin using baricitinib for the treatment of Covid-19 patients, especially category four and five patients, Health director-general Dr Noor Hisham Abdullah said.

He said the Health Ministry had received fresh allocation to use baricitinib which is seen to be effective when combined with dexamethasone.

Noor Hisham (above) said the use of baricitinib, which has a better effect, is hoped to increase the effectiveness of treatment for Covid-19 patients...